Waldencast plc Warrant (WALDW)

Obagi Medical introduces a new scalp serum clinically proven to reduce hair loss and promote fuller hair, targeting individuals experiencing hair thinning through a scientifically formulated product.

Waldencast has acquired Novaestiq Corp. and the U.S. rights to the Saypha® injectable hyaluronic acid gel line, expanding Obagi Medical's portfolio into dermal fillers and positioning the company at the intersection of skincare and aesthetic treatments.